Multimodal Therapy With Metformin, Inositol and Dietary Restriction Improves Insulin Resistance and Endocrine Outcomes in Women With Polyendocrine Metabolic Ovarian Syndrome: A Randomized Controlled Trial
Clinical Endocrinology · 2026-10 · 105 (4) · 505-513
DOI: 10.1111/cen.70188 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Endocrinology, online erschienen am 28.07.2026. Verfasst von Noor-Ul-Ain Irfan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Federal Medical College, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Metformin, Inositol, Insulin Resistance, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), is a common endocrine–metabolic disorder characterized by insulin resistance, hyperandrogenism and ovulatory dysfunction. Metformin, inositol supplementation and lifestyle modification are widely used treatments, but direct comparative evidence remains limited. Multimodal therapy combining metformin, inositol and dietary restriction produces greater metabolic and reproductive improvement than single‐modality interventions.
Methods
We conducted a 12‐week randomized controlled trial in 192 women aged 18–35 years diagnosed with PMOS according to Rotterdam criteria. Participants were allocated to metformin (1500–2000 mg/day), inositol (myo‐inositol 2 g plus d ‐chiro‐inositol 50 mg twice daily), calorie‐restricted diet (1200–1500 kcal/day), or combination therapy. Primary outcomes included changes in body mass index (BMI) and insulin resistance assessed by HOMA‐IR. Secondary outcomes included testosterone, LH/FSH ratio and menstrual regularity. Analysis was performed using analysis of covariance (ANCOVA), with post‐intervention values as dependent variables and corresponding baseline values as covariates. Categorical outcomes were compared using the Chi‐square test.
Results
All interventions improved metabolic and endocrine parameters. Combination therapy resulted in the greatest reduction in HOMA‐IR (− 2.64, 95% CI − 2.82 to −2.46, p < 0.001) and BMI (− 2.8 kg/m 2 , 95% CI − 3.05 to −2.55, p < 0.001). Menstrual cyclicity improved across all groups, with the highest proportion of participants reporting cycle regularisation in the combination therapy group (85.4%), compared with dietary restriction (72.9%), inositol (64.6%), and metformin (39.6%) ( p < 0.001). Given the short follow‐up duration, these findings reflect early improvements rather than sustained normalisation.
Conclusion
Multimodal therapy was associated with superior metabolic and reproductive outcomes compared with single‐modality interventions in women with PMOS. Clinical trial registration ClinicalTrials. gov (NCT07380841)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Federal Medical College, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan.
- Department of Physiology, Islamabad Medical and Dental College, Islamabad, Pakistan.
ORCID-Profile: Noor-Ul-Ain Irfan, Shemaila Saleem, Asma Irfan
Zitieren
APA
Irfan, N. U., Saleem, S., & Irfan, A. (2026). Multimodal Therapy With Metformin, Inositol and Dietary Restriction Improves Insulin Resistance and Endocrine Outcomes in Women With Polyendocrine Metabolic Ovarian Syndrome: A Randomized Controlled Trial. Clinical Endocrinology, 105(4), 505-513. https://doi.org/10.1111/cen.70188
Vancouver
Irfan NU, Saleem S, Irfan A. Multimodal Therapy With Metformin, Inositol and Dietary Restriction Improves Insulin Resistance and Endocrine Outcomes in Women With Polyendocrine Metabolic Ovarian Syndrome: A Randomized Controlled Trial. Clinical Endocrinology. 2026;105(4):505-513. doi:10.1111/cen.70188
BibTeX
@article{Irfan2026,
author = {Irfan, Noor-Ul-Ain and Saleem, Shemaila and Irfan, Asma},
title = {Multimodal Therapy With Metformin, Inositol and Dietary Restriction Improves Insulin Resistance and Endocrine Outcomes in Women With Polyendocrine Metabolic Ovarian Syndrome: A Randomized Controlled Trial},
journal = {Clinical Endocrinology},
year = {2026},
volume = {105},
number = {4},
pages = {505--513},
doi = {10.1111/cen.70188}
}
EUVIMED